Project description
Development of allergenicity prediction toolbox for novel foods
Novel foods such as insects will fill our plates, and contribute to the security and sustainability of our food supply. However, these foods need to be safe. Allergenicity assessment is important for the safety assessment. Unfortunately, current methods to assess de novo allergenicity lack predictive power and are not validated. Supported by the Marie Skłodowska-Curie Actions programme, the ALLPreT project will train the next generation of scientists to tackle the shortcomings in the current food allergy assessment of novel foods. Bringing together experts from universities, research institutes, hospitals, patient organisations and industry, ALLPreT will explore the new field of research on de novo sensitisation and develop a toolbox to facilitate allergenicity assessment, speeding up safety approval and market uptake of novel foods.
Objective
Introduction of novel foods, such as insects, will strongly contribute to the security and sustainability of our food supply. However, these novels foods need to be safe (EU regulation 2015/2283). Allergenicity assessment is an essential part of the safety assessment of novel foods. Unfortunately, current methods to assess de novo allergenicity lack predictive power and are not validated. Consequently, food producers and risk assessors struggle with allergenicity assessment, slowing down the introduction of novel foods in our food supply. Enabling the safe introduction of novel foods, while protecting humans from unacceptable food allergy risks, calls for a multidisciplinary approach. The ALLPreT consortium is a highly multidisciplinary group of experts from universities, research institutes, hospitals, patient organisations and industry arising from the EU COST Action ImpARAS (Improved Allergenicity Risk Assessment Strategy). This puts them in an ideal position to consolidate their previous collaboration and set up an innovative doctoral training network in this area. The overall goal of ALLPreT is to train the next generation of scientists who can tackle the shortcomings in the current food allergy assessment of novel food products. ALLPreT will train early stage researchers (ESRs) in the core aspects of food allergy risk assessment, immunology, protein chemistry, bioinformatics, in vitro/in vivo/in silico model development and complementary “soft” skills to deliver well educated young scientists, with a unique position within the EU labour market. The ESRs will explore the new field of research on de novo sensitisation by novel foods and develop a toolbox of in vitro/in vivo/in silico allergenicity prediction tools that are scientifically sound, validated and easily usable by industry and food safety authorities. This toolbox will contribute to fast and accurate safety assessment, thereby speeding up safety approval and market uptake of novel foods.
Fields of science
- medical and health sciencesclinical medicineallergologyfood allergy
- medical and health sciencesbasic medicineimmunology
- engineering and technologyother engineering and technologiesfood technologyfood safety
- natural sciencesbiological scienceszoologyentomology
- social scienceseconomics and businessbusiness and managementemployment
Keywords
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
HORIZON-TMA-MSCA-DN - HORIZON TMA MSCA Doctoral NetworksCoordinator
3584 CX Utrecht
Netherlands
See on map
Participants (8)
2800 Kongens Lyngby
See on map
1090 Wien
See on map
75007 Paris
See on map
5020 Salzburg
See on map
11001 Beograd
See on map
1431 Sofia
See on map
1445 Strassen
See on map
63225 Langen
See on map
Partners (15)
2595 DA Den Haag
See on map
50131 Johnston
See on map
62136 Lestrem
See on map
821 05 Bratislava
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
CF23 8HA CARDIFF
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2970 Hoersholm
See on map
1230 Wien
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
8200 Aarhus
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
2613 AX Delft
See on map
LS2 9JT Leeds
See on map
75116 Paris
See on map
35390 Giessen
See on map
3862 CG Nijkerk Gld
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
3584 CS Utrecht
See on map
4365 ESCH-SUR-ALZETTE
See on map